Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1977 Dec;6(6):574–577. doi: 10.1128/jcm.6.6.574-577.1977

Clinical evaluation of commercial conjugates for direct immunofluorescence of herpes simplex virus.

J G Gittzus, S J Rubin
PMCID: PMC274827  PMID: 73546

Abstract

Commercially prepared antibody conjugates that are now available allow extensive application of direct immunofluorescence for diagnosing herpetic infections. Five of these conjugates--Microbiological Associates bivalent herpes antiserum (MBA-bivalent), MBA anti-herpes types 1 (MBA-1) and 2 (MBA-2), and Flow Laboratories anti-herpes types 1 (Flow-1) and 2 (Flow-2)--were compared for antibody titer, diagnostic accuracy, and nonspecific background staining on known infected tissue. Four of these were tested simultaneously on 75 clinical specimens. No attempt was made to differentiate between herpes simplex virus type 1 or type 2 infections. All antisera were comparable in titer and exhibited fluorescence with both herpes simplex virus types 1 and 2 antigens. The most significant difference was excessive nonspecific staining consistently seen with the MBA-2 conjugate. Overall, Flow-2 and MBA-bivalent antisera were preferable.

Full text

PDF
574

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Hutfield D. C. Herpes genitalis. Br J Vener Dis. 1968 Sep;44(3):241–250. doi: 10.1136/sti.44.3.241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Marks M. I. Rapid identification of herpes simplex virus in tissue culture by direct immunofluorescence. J Lab Clin Med. 1971 Dec;78(6):963–968. [PubMed] [Google Scholar]
  3. Nahmias A. J., Roizman B. Infection with herpes-simplex viruses 1 and 2. 1. N Engl J Med. 1973 Sep 27;289(13):667–674. doi: 10.1056/NEJM197309272891305. [DOI] [PubMed] [Google Scholar]
  4. Nahmias A., DelBuono I., Pipkin J., Hutton R., Wickliffe C. Rapid identification and typing of herpes simplex virus types 1 and 2 by a direct immunofluorescence technique. Appl Microbiol. 1971 Sep;22(3):455–458. doi: 10.1128/am.22.3.455-458.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Rubin S. J., Wende R. D., Rawls W. E. Direct immunofluorescence test for the diagnosis of genital herpesvirus infections. Appl Microbiol. 1973 Sep;26(3):373–375. doi: 10.1128/am.26.3.373-375.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Sim C., Watson D. H. The role of type specific and cross reacting structural antigens in the neutralization of herpes simplex virus types 1 and 2. J Gen Virol. 1973 May;19(2):217–233. doi: 10.1099/0022-1317-19-2-217. [DOI] [PubMed] [Google Scholar]
  7. Taber L. H., Brasier F., Couch R. B., Greenberg S. B., Jones D., Knight V. Diagnosis of herpes simplex virus infection by immunofluorescence. J Clin Microbiol. 1976 Mar;3(3):309–312. doi: 10.1128/jcm.3.3.309-312.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Vestergaard B. F., Thybo H. Rapid diagnosis and typind of herpesvirus hominis by the fluorescent antibody method. Scand J Infect Dis. 1974;6(2):113–116. doi: 10.3109/inf.1974.6.issue-2.03. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES